PFBT
ANIK icon

Parkside Financial Bank & Trust’s Anika Therapeutics ANIK Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$951 Hold
65
– – ﹤0.01% 2423
2026
Q1 		$943 Hold
65
– – ﹤0.01% 2379
2025
Q4 		$625 Buy
+65
New +$623 ﹤0.01% 2512
2023
Q4 		– Sell
-32
Closed -$597 – 2053
2023
Q3 		$597 Sell
32
-127
-80% -$2.63K ﹤0.01% 1901
2023
Q2 		$4.13K Hold
159
– – ﹤0.01% 1436
2023
Q1 		$4.57K Hold
159
– – ﹤0.01% 1392
2022
Q4 		$4.71K Hold
159
– – ﹤0.01% 1344
2022
Q3 		$4K Hold
159
– – ﹤0.01% 1268
2022
Q2 		$4K Buy
159
+115
+261% +$2.57K ﹤0.01% 1292
2022
Q1 		$1K Sell
44
-24
-35% -$732 ﹤0.01% 1688
2021
Q4 		$2K Buy
68
+13
+24% +$520 ﹤0.01% 1567
2021
Q3 		$2K Sell
55
-5
-8% -$206 ﹤0.01% 1513
2021
Q2 		$3K Buy
60
+5
+9% +$213 ﹤0.01% 1391
2021
Q1 		$2K Hold
55
– – ﹤0.01% 1460
2020
Q4 		$2K Buy
55
+38
+224% +$1.44K ﹤0.01% 1374
2020
Q3 		$1K Buy
+17
New +$614 ﹤0.01% 1273
2020
Q2 		– Sell
-10
Closed – – 1474
2020
Q1 		$0 Sell
10
-14
-58% -$566 ﹤0.01% 1418
2019
Q4 		$1K Hold
24
– – ﹤0.01% 1313
2019
Q3 		$1K Hold
24
– – ﹤0.01% 1283
2019
Q2 		$1K Buy
+24
New +$875 ﹤0.01% 1298
2019
Q1 		– Sell
-18
Closed -$1K – 1535
2018
Q4 		$1K Buy
18
+1
+6% +$36 ﹤0.01% 1152
2018
Q3 		$1K Buy
+17
New +$672 ﹤0.01% 1199
2018
Q2 		– Sell
-13
Closed -$1K – 1526
2018
Q1 		$1K Buy
13
+9
+225% +$508 ﹤0.01% 1110
2017
Q4 		$0 Hold
4
– – ﹤0.01% 1357
2017
Q3 		$0 Buy
+4
New +$209 ﹤0.01% 1363

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Parkside Financial Bank & Trust's ANIK Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Anika Therapeutics (ANIK) position steady in Q2 2026 at 65 shares worth $951. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Parkside Financial Bank & Trust first reported a position in ANIK in Q3 2017 and has held it in 25 quarters since. The position peaked at $4.71K in Q4 2022. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Parkside Financial Bank & Trust held 65 shares of Anika Therapeutics worth $951 as of Q2 2026.
  • Parkside Financial Bank & Trust left its Anika Therapeutics share count unchanged in Q2 2026.
  • Anika Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2423 holding.
  • Parkside Financial Bank & Trust first reported a position in Anika Therapeutics in Q3 2017 and has held it in 25 quarters since.
  • Parkside Financial Bank & Trust's Anika Therapeutics position peaked at $4.71K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.